Sangamo Therapeutics
SGMO
#8081
Rank
A$0.34 B
Marketcap
$1.65
Share price
4.00%
Change (1 day)
24.57%
Change (1 year)

Earnings for Sangamo Therapeutics (SGMO)

Earnings in 2024 (TTM): -A$0.21 Billion

According to Sangamo Therapeutics 's latest financial reports the company's current earnings are A$52.29 Million. In 2023 the company made an earning of -A$0.19 Billion, an increase over its 2022 earnings that were of -A$0.32 Billion. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Sangamo Therapeutics from 2000 to 2024

Annual earnings

Year Earnings Change
2024 (TTM) -A$0.21 Billion6.66%
2023 -A$0.19 Billion-40.88%
2022 -A$0.32 Billion9.79%
2021 -A$0.3 Billion41.52%
2020 -A$0.21 Billion23.17%
2019 -A$0.17 Billion36.33%
2018 -A$0.13 Billion36.89%
2017 -A$89.42 Million-22.32%
2016 -A$0.12 Billion54.86%
2015 -A$74.34 Million75.62%
2014 -A$42.33 Million0.13%
2013 -A$42.28 Million
2011 -A$56.83 Million43.66%
2010 -A$39.56 Million28.52%
2009 -A$30.79 Million-23.55%
2008 -A$40.27 Million2.45%
2007 -A$39.3 Million19.5%
2006 -A$32.89 Million50.78%
2005 -A$21.82 Million75%
2004 -A$12.47 Million-33.25%
2003 -A$18.68 Million-62.27%
2002 -A$49.49 Million102.82%
2001 -A$24.41 Million23.21%
2000 -A$19.81 Million

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
A$0.27 B-231.13%๐Ÿ‡บ๐Ÿ‡ธ USA
-A$0.38 Billion 75.47%๐Ÿ‡บ๐Ÿ‡ธ USA
A$7.31 B-3,533.89%๐Ÿ‡บ๐Ÿ‡ธ USA
A$3.02 B-1,520.05%๐Ÿ‡บ๐Ÿ‡ธ USA
A$2.53 B-1,292.06%๐Ÿ‡บ๐Ÿ‡ธ USA
A$27.67 B-13,094.99%๐Ÿ‡บ๐Ÿ‡ธ USA
A$0.62 B-391.65%๐Ÿ‡บ๐Ÿ‡ธ USA
A$23.75 B-11,255.48%๐Ÿ‡บ๐Ÿ‡ธ USA